Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

The Effect of Sensory Awareness Training Given to Women of Reproductive Age on Dysmenorrhea and Kinesiophobia

NCT07097285 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-12-01
Last updated
2025-08-22

Condition(s) studied

DysmenorrheaKinesiophobia

Investigational drug(s) / intervention(s)

sensory awareness training

sensory awareness training: Presentations to inform during training will be done, then Graded Sensory Discrimination, Graded Motor Imagery (DMI) and a home exercise program, as well as a body awareness training program. protocol will be applied. Graded Sensory Discrimination protocol, localization training It includes level 1, localization training level 2 and graphesthesia training. Graded Engine Visualization (DMI) protocol includes right/left discrimination training and visual imagery training.

Study summary

This research investigates the use of web-based sensory awareness training given to women of reproductive age. It was planned to examine the effect of dysmenorrhea level and kinzeophobia status.H0a = Body weight of women of reproductive age who received and did not receive sensory awareness training. There is no difference between awareness levels.

H1a = Body size of women of reproductive age who receive and do not receive sensory awareness training. There is a difference between awareness levels.

H0b = Dysmenorrhea of women of reproductive age who received or did not receive sensory awareness training. There is no difference between the levels.

H1b = Dysmenorrhea among women of reproductive age who received and did not receive sensory awareness training. There is a difference between the levels.

H0c = Kinesiophobia in women of childbearing age who received or did not receive sensory awareness training. There is no difference between the situations.

H1c = Kinesiophobia in women of reproductive age who receive and do not receive sensory awareness training. There is a difference between situations Sensory awareness training was given to women in the intervention group of the study for 4 weeks. will be given. Training contents, Sensory System Training Presentation, Proprioception and Kinesthesia Sensory Training Presentation, Interoception Sense Training Presentation will be given, then Graded Sensory Discrimination, Graded Motor Imagery (DMI), interoception awareness training, body training with training consisting of interoceptive awareness exercises and home exercise programs. A protocol for awareness training will be implemented.

Eligibility

Sex
FEMALE
Min age
19 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Volunteering to participate in research * Having a complaint of dysmonea * Being of childbearing age * Being over 19 years old * Having internet access * Having a smart mobile phone Exclusion Criteria: * Be pregnant * Having any disease that affects the menstrual period * Using oral contraceptives * Using intrauterine device

Primary outcome measure(s)

  • Introductory Information Form — Baseline
    In this form created by researchers based on the literature, There are questions about the participants' age, the high school they graduated from, dysmenorrhea and kinesiophobia is taking.
  • Tampa Kinesiophobia Scale — day 1
    Tampa Kinesiophobia Scale (TCS) Miller, Kori and Todd It is a scale developed by in 1991. Fear of movement and re-injury, and It was developed to evaluate avoidance behavior due to fear. It was adapted to Turkish by Yılmaz et al. in 2011 and tested for validity and reliability. study has been done. The scale consists of 17 questions. On the scale, "1" means "strongly disagree" and "2" means "strongly disagree." from "1" to "4", where "I disagree", "3" I agree, "4" I completely agree. Varying Likert scoring is used. An individual can get a total score between 17-68, A high score indicates that the individual has high kinesiophobia.
  • Dysmenorrhea Affect Scale — day 1
    Validity and reliability study by Gün (2014) The Dysmenorrhea Exposure Scale (DES) was used to measure women's periods of menstrual pain. It is designed to identify problems and coping methods. A total of items 39 and 11 It consists of sub-dimensions. The Cronbach's Alpha coefficient of the scale is 0.90. Participants each rated the item on a 5-point scale ranging from 'I totally disagree (1)' to 'I totally agree (5)'. It evaluates on a Likert type scale. As the score obtained from the scale increases, people's The level of being affected by dysmenorrhea also increases. The lowest score that can be obtained from the scale is , The highest score is 195.
  • Multidimensional Body Awareness Assessment-II Scale — day 1
    Body Awareness has multiple developed by Mehling, Acree, Stewart, Silas and Jones to measure the dimensions of The Turkish adaptation of the scale was made by Mungurlar and Kahya. Scale, It is a self-report scale consisting of one item and eight factors. These factors; "Noticing", "Attention "Not Distracting", "Not Worrying", "Regulating Attention", "Emotional Awareness", "Self-Regulation", "Listening to the Body" and "Trusting". Evaluation of the scale is 1-5 points and is made by averaging the scoring factors separately. of scale Validity reliability Cronbach's alpha coefficient was determined as 0.88. As the score obtained from the scale increases, it means that people have more positive body awareness.

Trial sites (1)

FacilityCityRegionStatus
Sağlık Bilimleri Üniversitesi Istanbul Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07097285 on ClinicalTrials.gov ↗ ← All trials in Turkey